Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 23, 2013 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Doses First Patient in Phase 1/2 Trial With BMN 190 for the Treatment of Neuronal Ceroid Lipofuscinosis Type 2, a Form of Batten Disease

SAN RAFAEL, Calif., Sept. 23, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that it has dosed the first patient in the Phase 1/2 trial for BMN 190, a recombinant...
September 23, 2013 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Attend NewsMakers in the Biotech Industry Conference

SAN RAFAEL, Calif., Sept. 23, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Dan Spiegelman, Chief Financial Officer at BioMarin, will present a company...
September 17, 2013 08:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Provides Highlights Ahead of Research and Development Day

Vimizim: Regulatory applications on track. FDA Advisory Committee Meeting expected to be scheduled for November 19, 2013. BMN 701: Maximal Inspiratory Pressure (MIP) accepted by FDA as...
September 05, 2013 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Host a Research and Development Day on September 17th

SAN RAFAEL, Calif., Sept. 5, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) will host a Research and Development Day for the investment community on Tuesday, September 17, 2013...
September 03, 2013 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Attend Upcoming Conferences: Citi Biotech Day, Morgan Stanley Global Healthcare Conference and Baird Healthcare Conference

SAN RAFAEL, Calif., Sept. 3, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that BioMarin will attend the Citi Biotech Day in Boston on September 4th, the Morgan...
September 03, 2013 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Appoints Richard Ranieri as Senior Vice President, Human Resources and Corporate Affairs

SAN RAFAEL, Calif., Sept. 3, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced the appointment of Richard Ranieri as Senior Vice President, Human Resources and...
August 16, 2013 18:10 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Announces Oral Presentation of BMN 673 Most Recent Data on Breast and Ovarian Cancers at the European Cancer Congress 2013

SAN RAFAEL, Calif., Aug. 16, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that its abstract, PARP inhibition with BMN 673 in ovarian and breast cancer patients...
July 25, 2013 16:05 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Provides BMN 673 Program Update

RECIST Response Rate Increases to 50% in gBRCA Breast Cancer; Study Ongoing Phase 3 Trial to Start in 3Q 2013 National Breast Cancer Coalition Announces Intention to Assist With Trial...
July 25, 2013 16:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Announces Second Quarter 2013 Financial Results

Total Revenue Growth Exceeds 10 Percent Phase 3 Trial to Start in 3Q 2013 Conference Call and Webcast to be Held Today at 5:00 p.m. ET Financial Highlights ($ in millions,...
July 03, 2013 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Host Second Quarter 2013 Financial Results Conference Call and Webcast on Thursday, July 25 at 5:00 p.m. ET

SAN RAFAEL, Calif., July 3, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will host a...